FOR RESEARCH PURPOSES ONLY — NOT FOR HUMAN CONSUMPTION
Free Shipping from 100 EUR/ COA Verified — Third Party Tested/ Fast EU Delivery — Ships from Europe/ cGMP Certified Supplier/ Trusted by Research Professionals/ >98% Purity Guaranteed/ Free Shipping from 100 EUR/ COA Verified — Third Party Tested/ Fast EU Delivery — Ships from Europe/ cGMP Certified Supplier/ Trusted by Research Professionals/ >98% Purity Guaranteed/
Shop All Performance & Recovery Anti-Aging & Longevity Research About Terms Privacy
PRODUCT PHOTO PREMIUM
PERFORMANCE & RECOVERY / PREMIUM

KLOW Blend

BPC-157 + TB-500 + GHK-Cu + KPV — Lyophilized Vial

EUR 149.90
COA Verified Third Party Tested >98% Purity 4 Peptides
BUY NOW

Description

The KLOW Blend is the most comprehensive recovery research stack available, combining four synergistic peptides in a single lyophilized vial: BPC-157, TB-500, GHK-Cu, and KPV. Each component targets a distinct molecular pathway involved in tissue repair, inflammation modulation, and cellular regeneration, creating a multi-vector research model that no single peptide can replicate. This premium formulation is designed for advanced research protocols requiring simultaneous investigation of complementary recovery mechanisms.

BPC-157 (Body Protection Compound-157) is a synthetic gastric pentadecapeptide that has demonstrated significant tissue repair activity across preclinical models. Its primary mechanisms include upregulation of vascular endothelial growth factor (VEGF) receptor expression, promotion of angiogenesis, and interaction with the nitric oxide system. Published research documents accelerated healing of tendons, ligaments, muscles, and gastrointestinal mucosa in rodent injury models. BPC-157 provides the foundational tissue repair component of the KLOW Blend, addressing vascular supply and structural tissue regeneration at the wound site level.

TB-500, a synthetic fragment of Thymosin Beta-4, operates through a fundamentally different mechanism centered on actin sequestration and regulation of cell migration. By binding to G-actin monomers, TB-500 promotes cytoskeletal reorganization that enables endothelial cells, keratinocytes, and other repair-associated cell types to migrate into damaged tissue. Its anti-inflammatory activity has been documented through downregulation of pro-inflammatory cytokines including IL-1beta and TNF-alpha. Where BPC-157 builds the vascular infrastructure for repair, TB-500 facilitates the cellular migration required to populate and reconstruct the damaged tissue architecture.

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide that acts as a potent signaling molecule for extracellular matrix remodeling. Research has identified over 4,000 genes whose expression is modulated by GHK-Cu, with particular relevance to collagen synthesis, decorin production, and stem cell recruitment. The copper ion is integral to the peptide's activity, serving as a cofactor for lysyl oxidase, the enzyme responsible for collagen and elastin cross-linking. GHK-Cu adds a matrix remodeling and regenerative signaling dimension that complements the direct tissue repair activities of BPC-157 and TB-500.

KPV is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH) consisting of the amino acid sequence Lys-Pro-Val. Despite its small size, KPV retains the potent anti-inflammatory and antimicrobial properties of the parent hormone while lacking its melanogenic effects. Research has demonstrated that KPV inhibits NF-kB nuclear translocation, a master regulator of inflammatory gene expression, and exhibits direct antimicrobial activity against several bacterial strains relevant to wound infection models. KPV provides the anti-inflammatory and antimicrobial layer of the KLOW Blend, addressing the immune and infection control aspects of the recovery environment.

The value proposition of the KLOW Blend is substantial: purchasing these four peptides individually would cost significantly more than the combined formulation, while the co-lyophilization ensures precise ratios and eliminates the variability inherent in manual reconstitution and mixing of separate vials. Each component exceeds 98% purity as verified by independent HPLC analysis. Reconstitute with bacteriostatic water prior to use in research applications.

Composition

Storage

Certificate of Analysis

Every batch of KLOW Blend sold by Pepspan undergoes comprehensive multi-component third-party testing. Our Certificate of Analysis (COA) includes individual HPLC purity analysis for all four peptide components (BPC-157, TB-500, GHK-Cu, and KPV), mass spectrometry confirmation of each peptide, endotoxin testing, and sterility verification. COA documentation is available upon request for any batch number. All testing is performed by independent European laboratories to ensure the highest standards of accuracy and reliability.

Batch Purity Report

Janoshik Verified

Current Batch: Pending first shipment

Every batch of KLOW Blend sold by Pepspan is independently tested by Janoshik Analytical (Prague, Czech Republic). HPLC purity analysis, mass spectrometry, and amino acid sequencing are performed for each shipment. Reports are batch-specific — not generic.

View All Purity Reports →

Research Disclaimer

All products on this website are sold strictly for research purposes only. Not intended for human or animal consumption. Must be handled by qualified professionals. Keep out of reach of children. By purchasing, you confirm you are a qualified researcher and will use these products solely for scientific research. The KLOW Blend is not approved for human or veterinary use by any regulatory agency. It must not be administered to humans or animals outside of approved clinical trials. Pepspan assumes no liability for any misuse of this product. All handling must comply with local regulations and institutional safety protocols.